Publication Cover
Journal of Neurotherapy
Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience
Volume 5, 2001 - Issue 1-2
30
Views
3
CrossRef citations to date
0
Altmetric
CURRENT CONCEPTS IN NEUROTHERAPY

Pills, Politics, and Placebos

Pages 73-86 | Published online: 08 Sep 2008

REFERENCES

  • Ader , R. , Grota , L. J. and Cohen , N. 1987 . Conditioning phenomena and immune function. . Annals of the New York Academy of Science , 496 : 532
  • Arnold , L. E. Treatment alternatives for attention deficit hyperactivity disorder. Paper presented at the NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, Bethesda, MD . lpar;November 16–18
  • Barkley , R. A. 1992 . “ Is EEG biofeedback treatment effective for ADHD children? ” . In Ch.A.D.D.er Box, 5–11.
  • Basmajian , J. V. 1999 . The third therapeutic revolution: Behavioral medicine. . Applied Psychophysiology and Biofeedback , 24 ( 2 ) : 107 – 116 .
  • Beecher , H. K. 1955 . The powerful placebo. . Journal of the American Medical Association , 159 ( 17 ) : 1602 – 1606 .
  • Bergmann , J. F. , Chassany , O. , Gandiol , J. , Deblois , P. , Kanis , J. A. , Segrestaa , J. M. , Caulin , C. and Dahan , R. 1994 . A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. . Clinical Trials and Meta-Analysis , 29 ( 1 ) : 41 – 47 .
  • Blackwelder , W. C. 1982 . “Proving the null hypothesis” in clinical trials. . Controlled Clinical Trials , 3 ( 4 ) : 345 – 353 .
  • Duffy , F. H. 2000 . The state of EEG biofeedback therapy (EEG operant conditioning) in 2000: An editor's opinion. . Clinical Electroencephalography , 31 ( 1 ) : V-VIII
  • FDA . 1996a . “ ICH E3. Guidelines for industry: Content and structure of clinical study reports. [Online]. Available: ” . http://www.fda.gov/cder/guidance/index.htm
  • FDA . 1996b . “ ICH E6. Guidance for industry: Good clinical practice. [Online]. Available: ” . http://www.fda.gov/cder/guidance/index.htm
  • FDA . 1997 . “ ICH E8. General considerations for clinical trials. [Online]. Available: ” . http://www.fda.gov/cder/guidance/index.htm
  • Fenger , T. N. 1998 . Visual-motor integration and its relation to EEG neurofeedback brain wave patterns, reading, spelling, and arithmetic achievement in attention deficit disordered and learning disabled students. . Journal of Neurotherapy , 3 ( 1 ) : 11 – 20 .
  • Freedman , B. , Glass , K. C. and Weijer , C. 1996 . Placebo orthodoxy in clinical research. II: Ethical, legal, and regulatory myths. . Journal of Law, Medicine & Ethics , 24 ( 3 ) : 252 – 259 .
  • Freedman , B. , Weijer , C. and Glass , K. C. 1996 . Placebo orthodoxy in clinical research. I: Empirical and methodological myths. . Journal of Law, Medicine & Ethics , 24 ( 3 ) : 243 – 251 .
  • Freeman , T. , Vawter , D. , Leaverton , P. , Godbold , J. , Hauser , R. and Goetz , C. 1999 . Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. . New England Journal of Medicine , 341 : 988 – 992 .
  • Fu , W. K. 2000 . Re: Randomized controlled trials in surgery: An essential component of scientific progress (Spine 1999; 24: 2553–5rpar; [letter; comment] . Spine , 25 ( 15 ) : 2002 – 2004 .
  • Fuchs , T. 1999 . Aufmerksamkeit und neurofeedback: Evaluation eines psychophysiologischen eeg-biofeedback-behandlungs programms bei aufmerksamkeits und hyperaktivitatsstorungen in kinesalter (Attention and neurofeedback: An evaluation of a psychophysiological EEG biofeedback treatment program for childhood attention-deficit/hyperactivity disorders). , Regensburg : Roderer. .
  • Glaros , A. G. 2001 . A comment on La Vaque and Rossiter. . Applied Psycho-physiology and Biofeedback , 26 ( 1 ) : 61 – 65 .
  • Hammerschlag , R. 1998 . Methodological and ethical issues in clinical trials of acupuncture. . Journal of Alternative and Complementary Medicine , 4 ( 2 ) : 159 – 171 .
  • Harrington , A. November 19–21 2000 . “Seeing” the placebo effect: Historical legacies and present opportunities ” . In Paper presented at The Science of the Placebo: Toward an Interdisciplinary Research Agenda , November 19–21 , Bethesda, MD : National Institutes of Health .
  • Jarrett , R. B. , Schaffer , M. , McIntire , D. , Witt-Browder , A. , Kraft , D. and Risser , R. C. 1999 . Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. . Archives of General Psychiatry , 56 ( 5 ) : 431 – 437 .
  • Kienle , G. S. and Kiene , H. 1996 . Placebo effect and placebo concept: A critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. . Alternative Therapies in Health and Medicine , 2 ( 6 ) : 39 – 54 .
  • Kienle , G. S. and Kiene , H. 1997 . The powerful placebo effect: Fact or fiction? . Journal of Clinical Epidemiology , 50 ( 12 ) : 1311 – 1318 .
  • La Vaque , T. J. 1999 . Neurotherapy and clinical science. . Journal of Neurotherapy , 3 ( 3 & 4 ) : 29 – 31 .
  • La Vaque , T. J. and Rossiter , T. R. 2001a . The ethical use of placebo controls in clinical research: The Declaration of Helsinki. . Applied Psychophysiology and Biofeedback , 26 ( 1 ) : 23 – 37 .
  • La Vaque , T. J. and Rossiter , T. R. 2001b . Response to Striefel and Glaros. . Applied Psychophysiology and Biofeedback , 26 ( 1 ) : 67 – 71 .
  • Levin , J. S. , Glass , T. A. , Kushi , L. H. , Schuck , J. R. , Steele , L. and Jonas , W. B. 1997 . Quantitative methods in research on complementary and alternative medicine. A methodological manifesto. NIH Office of Alternative Medicine. . Medical Care , 35 ( 11 ) : 1079 – 1094 .
  • Lurie , P. 1999 . “ The use of placebos in clinical trials and the ethics of the use of placebos. ” . In Paper presented at the Committee for Advanced Scientific Education Seminar Series, Rockville, MD (April 21
  • Lurie , P. and Wolfe , S. 1997 . Unethical trials of interventions to reduce perinatal transmission of the Human Immunodeficiency Virus in developing countries. . New England Journal of Medicine , 337 ( 12 ) : 853 – 856 .
  • Macklin , R. 1999 . The ethical problems with sham surgery in clinical research. . New England Journal of Medicine , 341 ( 13 ) : 992 – 996 .
  • McNeill , P. M. 1998 . Should research ethics change at the border? (editorial). . The Medical Journal of Australia , 169 : 509 – 510 .
  • NCCAM. (Winter . 2000 . NCCAM Advisory Council reviews first year: Striving for excellence in CAM research. . Complimentary and Alternative Medicine at the NIH , 7 : 1 – 8 .
  • NIH. (November 19–21 . The science of the placebo: Toward an interdisciplinary research agenda . Bethesda, MD : Natcher Conference Center .
  • Norris , S. L. , Lee , C. , Cea , J. and Burshteyn , D. 1998 . Performance enhancement training effects on attention: A case study. . Journal of Neurotherapy , 3 ( 1 ) : 21 – 27 .
  • Quitkin , F. M. 1999 . Placebos, drug effects, and study design: A clinician's guide. . American Journal of Psychiatry , 156 ( 6 ) : 829 – 836 .
  • Ramos , F. 1998 . Frequency band interaction in ADD/ADHD neurotherapy. . Journal of Neurotherapy , 3 ( 1 ) : 28 – 46 .
  • Ramsay , S. 1999 . More developments in developing-world research ethics (news). . Lancet , 354 ( 9188 ) : 1405 – 1406 .
  • Rossiter , T. R. and La Vaque , T. J. 1995 . A comparison of EEG biofeedback and psychostimulants in treating attention deficit hyperactivity disorders. . Journal of Neurotherapy , 1 ( 1 ) : 48 – 59 .
  • Rothman , D. J. 1987 . Ethical and social issues in the development of new drugs and vaccines. . Bulletin of the New York Academy of Medicine , 63 ( 6 ) : 557 – 568 .
  • Rothman , K. J. 2000 . Declaration of Helsinki should be strengthened. . British Medical Journal , 321 ( 7258 ) : 442 – 445 .
  • Rothman , K. J. and Michels , K. B. 1994 . The continuing unethical use of placebo controls. . New England Journal of Medicine , 331 ( 6 ) : 394 – 397 .
  • Striefel , S. 2001 . Ethical research issues: Going beyond the Declaration of Helsinki. . Applied Psychophysiology and Biofeedback , 26 ( 1 ) : 39 – 59 .
  • Temple , R. 1999 . “ The use of placebos in clinical trials and the ethics of the use of placebos. ” . In Paper presented at the Committee for Advanced Scientific Education Seminar Series, Rockville, MD (April 21
  • Temple , R. and Ellenberg , S. S. 2000 . Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. . Annals of Internal Medicine , 133 ( 6 ) : 455 – 463 .
  • Wadhwani , S. , Radvanski , D. C. and Carmody , D. 1998 . Neurofeedback training in a case of attention deficit hyperactivity disorder. . Journal of Neurotherapy , 3 ( 1 ) : 42 – 49 .
  • Wickramasekera , I. 1998 . Secrets kept from the mind but not the body or behavior: The unsolved problems of identifying and treating somatization and psychophysiological disease. . Advances in Mind-Body Medicine , 14 : 52
  • WMA . 2000 . “ The Declaration of Helsinki. ” . In Paper presented at the 52nd WMA General Assembly, Edinburgh, Scotland
  • Woodman , R. 1999 . Storm rages over revisions to Helsinki Declaration [news]. . British Medical Journal , 319 ( 7211 ) : 660

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.